Protagonist Therapeutics, Inc — Director's Dealing 2016

Oct 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2016-10-11

Reporting Person: PATEL DINESH V PH D (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-11	Stock Option (right to buy)	$21.58	A	320000	Acquired	2026-10-11	Common Stock (320000)	Direct

Footnotes

F1: The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016.